GLUCOSYLCERAMIDE
|
|
|
- CAS号:
- 85305-87-9
- 英文名:
- GLUCOSYLCERAMIDE
- 英文别名:
- s spleen);GangliosideGL1a;Gulcocerebroside;GLUCOSYLCERAMIDE;SOYBEAN GLUCOCEREBROSIDES;Glucosylceramides from wheat;Glucosylceramide (d18:1/18:0);Glucosylceramide (d18:1/20:0);Glucosylceramide (d18:1/16:0);Glucosylceramide (d18:1/12:0)
- 中文名:
- GLUCOSYLCERAMIDE
- 中文别名:
- 化合物 GLUCOCEREBROSIDES;Glucocerebrosides (Gaucher抯 spleen);小麦糖基/HPLC/MIXTUREOFGLUCOSYLCERAMIDES;Glucosylceramide (gaucher's spleen)试剂;Glucosylceramide (gaucher's spleen)试剂
- CBNumber:
- CB9471779
- 分子式:
- C9H18N2O7
- 分子量:
- 266.25
- MOL File:
- 85305-87-9.mol
|
|
|
GLUCOSYLCERAMIDE化学性质
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
Chloroform:Methanol (2:1): soluble
-
|
-
形态:
-
A solid
-
|
-
颜色:
-
White to off-white
-
|
GLUCOSYLCERAMIDE性质、用途与生产工艺
Glucosylceramides 是一类鞘脂分子，存在于神经和非神经的哺乳动物组织中，并在多种植物中以低浓度存在。Glucosylceramides 水平升高可以提供细胞保护并为某些细胞的增殖做好准备，然而，它们也与小鼠中由肥胖引起的胰岛素抵抗以及神经病性戈谢病中观察到的神经缺陷有关。
GLUCOSYLCERAMIDE
上下游产品信息
上游原料
下游产品
85305-87-9, GLUCOSYLCERAMIDE 相关搜索:
双水杨酰胺乙基钴 苯硒酚 三乙酰丙酮铁 1,1,3,3-四甲基丁基异氰 2,2,6,6-四甲基-3,5-庚烷二酸镝 苄异腈 乙酰丙酮酸铜 异氰基乙酸乙酯 乙酰丙酮铬盐 对甲基苯磺酰甲基异腈 乙酰丙酮银 三(2,2,6,6-四甲基-3,5-庚二酸)铕 异腈基乙酸甲酯 异氰酸叔丁酯 异腈基正丁烷 三乙酰丙酮铝 乙酰丙酮钴水合物 乙二胺氯化铂
- 抑制剂
- C44H85NO8
- C42H81NO8
- C40H77NO8
- C36H69NO8
- C42H79NO8
- C50H95NO8
- C50H97NO8
- C49H95NO8
- C48H91NO8
- C48H93NO8
- C46H89NO8
- Glucosylceramide (gaucher's spleen)试剂
- Glucosylceramide (gaucher's spleen)试剂
- 小麦糖基/HPLC/MIXTUREOFGLUCOSYLCERAMIDES
- 化合物 GLUCOCEREBROSIDES
- Glucocerebrosides (Gaucher抯 spleen)
- 85305-87-9
- Glucocerebrosides (Gaucher's spleen)
- Glucosylceramides from wheat
- Glucosylceramide (Gaucher’s spleen)
- Glucosylceramides (Gaucher’s spleen)
- Glucocerebrosides (Gaucher&rsquo
- s spleen)
- GangliosideGL1a
- Ceramide,1-O-β-D-glucopyranosyl-
- beta-D-glucosyl-N-(dodecanoyl)sphingosine
- GLUCOSYLCERAMIDE, FROM HUMAN SPLEEN (GAUCHER''S)
- N-[(E,2S,3R)-3-hydroxy-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]tetracosanamide
- Glucosylceramide (d18:1/9Z-18:1)
- (Z)-N-((2S,3R,E)-3-hydroxy-1-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)octadec-4-en-2-yl)octadec-9-enamide
- GLUCOSYLCERAMIDE
- Glucosylceramide (d18:1/26:1(17Z))
- (Z)-N-((2S,3R,E)-3-hydroxy-1-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)octadec-4-en-2-yl)hexacos-17-enamide
- N-((2S,3R,E)-3-hydroxy-1-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)octadec-4-en-2-yl)hexacosanamide
- Glucosylceramide (d18:1/26:0)
- N-((2S,3R,E)-3-hydroxy-1-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)octadec-4-en-2-yl)pentacosanamide
- Glucosylceramide (d18:1/25:0)
- Glucosylceramide (d18:1/24:1(15Z))
- (Z)-N-((2S,3R,E)-3-hydroxy-1-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)octadec-4-en-2-yl)tetracos-15-enamide
- N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]tetracosanamide
- Glucosylceramide (d18:1/24:0)
- N-((2S,3R,E)-3-hydroxy-1-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)octadec-4-en-2-yl)docosanamide
- Glucosylceramide (d18:1/22:0)
- N-((2S,3R,E)-3-hydroxy-1-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)octadec-4-en-2-yl)icosanamide
- Glucosylceramide (d18:1/20:0)
- N-((2S,3R,E)-3-hydroxy-1-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)octadec-4-en-2-yl)octadecanamide
- Glucosylceramide (d18:1/18:0)
- N-((2S,3R,E)-3-hydroxy-1-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)octadec-4-en-2-yl)hexadecanamide
- Glucosylceramide (d18:1/16:0)
- N-((2S,3R,E)-3-hydroxy-1-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)octadec-4-en-2-yl)dodecanamide
- Glucosylceramide (d18:1/12:0)
- SOYBEAN GLUCOCEREBROSIDES
- Gulcocerebroside